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Abstract
Introduction
Introduction: Interleukin 6 (IL-6) is a pleiotropic soluble mediator which is involved with many different
parts of inflammatory processes. Studies have shown that there is a significantly higher concentration of
IL-6 in inflamed pulp tissues when compared to healthy pulp tissues. However, there are no
comprehensive studies on how IL-6 can interact with dental pulp stem cells (DPSCs) from healthy (HDPSCs) and inflamed pulp tissues (I-DPSCs) and how it can affect the differentiation potential of DPSCs.
Therefore, I hypothesized that IL-6 can promote osteogenesis while inhibiting neurogenesis from DPSCs.
The aims of this study were to investigate the baseline differences between the H-DPSCs and I-DPSCs,
and determine how IL-6 can affect the osteogenic and neurogenic differentiation potentials of DPSCs.
Materials and Methods: H-DPSCs and I-DPSCs were isolated and cultured from 28 teeth consisting
healthy impacted third molars (n=14) from patients with 17-27 years of age, and severely decayed molars
(n=14) with spontaneous, sharp pain from patients with 24 – 56 years of age, respectively. The levels of
IL-6 from H-DPSCs and I-DPSCs were measured by ELISA, and IL-6 and neutralizing IL-6 were added to HDPSCs and I-DPSCs, respectively. Immunofluorescence and Alizarin Red staining, and western blot were
performed to assess the differentiation potentials of DPSCs. The independent unpaired two-tailed
Student’s t-test were performed following quantification analysis.
Results: H-DPSCs and I-DPSCs showed similar expression of stem cell markers including CD44, CD73,
CD90, and CD105, while H-DPSCs showed lower level of IL-6 (p
Conclusion: This study showed IL-6 has the capacities to enhance osteogenesis while hindering
neurogenesis of DPSCs.
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ABSTRACT
The Role of IL-6 in Osteogenic and Neurogenic Differentiation
Potentials of Dental Pulp Stem Cells
Introduction: Interleukin 6 (IL-6) is a pleiotropic soluble mediator which is involved with
many different parts of inflammatory processes. Studies have shown that there is a
significantly higher concentration of IL-6 in inflamed pulp tissues when compared to
healthy pulp tissues. However, there are no comprehensive studies on how IL-6 can
interact with dental pulp stem cells (DPSCs) from healthy (H-DPSCs) and inflamed pulp
tissues (I-DPSCs) and how it can affect the differentiation potential of DPSCs. Therefore, I
hypothesized that IL-6 can promote osteogenesis while inhibiting neurogenesis from
DPSCs. The aims of this study were to investigate the baseline differences between the HDPSCs and I-DPSCs, and determine how IL-6 can affect the osteogenic and neurogenic
differentiation potentials of DPSCs.
Materials and Methods: H-DPSCs and I-DPSCs were isolated and cultured from 28 teeth
consisting healthy impacted third molars (n=14) from patients with 17-27 years of age, and
severely decayed molars (n=14) with spontaneous, sharp pain from patients with 24 – 56
years of age, respectively. The levels of IL-6 from H-DPSCs and I-DPSCs were measured
by ELISA, and IL-6 and neutralizing IL-6 were added to H-DPSCs and I-DPSCs,
respectively. Immunofluorescence and Alizarin Red staining, and western blot were
performed to assess the differentiation potentials of DPSCs. The independent unpaired
two-tailed Student’s t-test were performed following quantification analysis.
Results: H-DPSCs and I-DPSCs showed similar expression of stem cell markers including
CD44, CD73, CD90, and CD105, while H-DPSCs showed lower level of IL-6 (p<0.001),
lower osteogenic and higher neurogenic (p<0.001) differentiation potentials compared to IDPSCs. Addition of IL-6 to H-DPSCs increased the osteogenic potentials and decreased
the neurogenic potentials (p<0.001), while neutralization of IL-6 for I-DPSCs led to
decreased osteogenic potentials and increased neurogenic potentials (p<0.001).
Conclusion: This study showed IL-6 has the capacities to enhance osteogenesis while
hindering neurogenesis of DPSCs.
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LITERATURE REVIEW
Stem cells in Oral Cavity

Stem cells are one of the hottest topics in the field of research including both
medicine and dentistry in recent years, because they have been identified as a
promising source for many clinical applications including cell therapy and tissue
engineering.

Stem cells, by their definition, are unique for two distinct characteristics which are
the abilities to self-renew and to differentiate into different cell types (Egusa et al.,
2012). There are three types of stem cells: adult stem cells, embryonic stem cells
and induced pluripotent stem cells. Adult stem cells and embryonic stem cells are
naturally found in human body while induced pluripotent stem cells are
synthetically made through genetic manipulation of somatic cells (Takahasi, 2006).

Adult stem cells, including dental stem cells, are considered multipotent, meaning
they are able to differentiate into a few different types of cells, while embryonic
stem cells and induced pluripotent stem cells are considered pluripotent, meaning
they can differentiate into all cell types from three germinal layers (Egusa et al.,
2012).
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Adult stem cells are found in many tissues and organs in our body. Through selfrenewal and differentiation, adult stem cells work to keep healthy tissues and fix
injured tissues throughout the body. Many adult stem cells are located in certain
mesenchymal tissues and they are collectively called mesenchymal stem cells
(MSCs) (Hortwitz et al., 2005). Originally, MSCs have been identified in the bone
marrow, but similar types of MSCs have also been identified from many different
areas of the body, including adipose tissue, skin and dental tissues (Egusa et al.,
2007).

Recent studies have identified our oral cavity as a rich niche for many different
types of stem cells. These cells include bone marrow-derived MSCs (BMSCs) from
orofacial bone, dental pulp stem cells, stem cells from human exfoliated deciduous
teeth, periodontal ligament stem cells, dental follicle stem cells, tooth germ
progenitor cells, stem cells from the apical papilla, oral epithelial progenitor/stem
cells, gingiva-derived MSCs, periosteum-derived stem cells and salivary glandderived stem cells (Egusa et al., 2012).

Bone marrow stem cells possess a high replicative capacity and have the ability to
differentiate into different connective tissue cell types. In addition, they form bonelike structure in vivo, which makes them an attractive target for bone regeneration
therapy (Egusa et al., 2012). The orofacial MSCs are functionally different from
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other types of BMSCs with higher proliferation and osteogenic differentiation
capacity based on several studies (Igarashi et al., 2007).

In 2000, adult dental stem cells were first isolated from the dental pulp, then MSClike cells were subsequently isolated from the pulp of human deciduous teeth
(Gronthos et al., 2000). These cells possess characteristics of stem cell, including
the ability to self-renew and differentiate into multiple cell types (Shi et al., 2001).
A few years after the first discovery of adult stem cells from the dental pulp, MSClike cells were identified again from the periodontal ligament (Seo et al., 2004).
They have also demonstrated certain stem cell properties; additionally, they have
shown the ability to regenerate periodontal tissues in animal models (Seo et al.,
2004).

Based on active on-going research on stem cells, many promising studies are
being conducted for stem-cell-based therapy in dentistry, focusing on tissue
engineering and chair-side cellular grafting approaches. These studies are heading
to more predictable regenerative outcomes in the future using stem cells in oral
cavity (Egusa et al., 2012). These studies include alveolar bone augmentation,
tooth regeneration, salivary gland regeneration, mandible condyle regeneration,
tongue regeneration, cell-based immunotherapy and more (Egusa et al., 2012).
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Dental Pulp Stem Cells

As briefly mentioned above, dental pulp stem cells (DPSCs) were first isolated by
Gronthos et al., in 2000. These cells were isolated from adult human dental pulp
and were clonogenic and proliferative just like human BMSCs (Gronthos et al.,
2000). Although DPSCs and BMSCs showed similarities in immunophenotype in
vitro, they behave differently when transplanted into immunocompromised mice
(Egusa et al., 2012). DPSCs generated a dentin-like structure lined with human
odontoblast-like cells that surrounded a pulp-like interstitial tissue when
transplanted into immunocompromised mice, while BMSCs formed lamellar bone
with osteocytes and surface-lining osteoblasts, surrounding a fibrous vascular
tissue with active hematopoiesis adipocytes (Gronthos et al., 2000). This showed
that DPSCs have the ability to form a dentin/pulp-like complex.

DPSCs are commonly found within the “cell rich zone” of dental pulp tissues in
adult teeth (D’aquino et al., 2018). DPSCs have the potential to differentiate into
many different cell types in vitro such as osteoblasts, chondrocytes, adipocytes,
myocytes, neurons, and hepatocytes (Karamzadeh & Eslaminjad, 2013). The
current literatures indicate that DPSCs have the potential to differentiate into
odontoblast, dentin, dental pulp, bone, cartilage, muscle, hair follicle, neuronal cells,
cornea, melanocytes and endothelial cells (Kawashima, 2012). Studies have
shown that DPSCs are often inactive, but react quickly when there’s an injury. After
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an injury, these DPSCs react immediately to repair the tissue by differentiating into
osteoblasts, odontoblasts and chondrocytes to produce bone, dentin and cartilage
tissues (Potdar & Jethmalani, 2015).

The identification of DPSCs depends on the presence or absence of specific cell
surface markers. Unfortunately, there is no specific markers for DPSCs, because
they are a heterogeneous population (Kawashima, 2012). Common surface
markers for mesenchymal stem cells include STRO-1, CD29, CD44, CD73, CD90,
CD105, CD146, CD166 and CD271 (Kawashima, 2012). In addition, the negative
markers include HLA-DR and hematopoeitc antigens like CD34 and CD45
(Karamzadeh & Eslaminjad, 2013). DPSCs also contain stemness factors such as
OCT-3/4 and NANOG (Kawashima, 2012)

These cells have shown many characteristics that make them an attractive target
for research and future clinical applications. It has been reported that DPSCs can
be cryopreserved and stored for long periods of time, and they can still keep their
stem cell functions (D’aquino et al., 2018). Additionally, DPSCs have been heavily
studied for tissue engineering to promote 3-D tissue formation (D’aquino et al.,
2018).
From extracted human teeth, dental pulp tissues can be easily isolated and cells
can be enzymatically released from these tissues (Karamzadeh & Eslaminjad,
2013). After plating on a culture dish, DPSCs have the capacity to attach to the
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dish and form a single-colony cluster usually about two weeks after culture, and
these colonies include fibroblast-like cells and they are subjected to secondary ex
vivo culture to expand cell numbers (Liu et al., 2006).

The standard protocol for isolating DPSC from dental pulp tissue is very well
established from Liu et al., 2006. Steps include the following: 1. Collect freshly
extracted human teeth and place them into a sterile container with saline. Human
third molars are the most ideal source due to the fact that it’s one of the most
commonly extracted teeth and its optimal amount for dental pulp tissue. 2. Scrape
the tooth surface to remove any gingival or periodontal tissues. Disinfect the tooth
surface with iodine and 70% ethanol, and rinse 5 times with 1x phosphate-buffered
saline (PBS). 3. Cut around the cementum-enamel junction of the tooth with
sterilized high-speed dental burr to separate the crown and root, then the pulp
tissue will be exposed. 4. By using sterilized tweezers, pick up the pulp tissue.
Mince the pulp tissues with a scalpel with moisture from culture medium like alphaMEM. By using a mixture of collagenase type I (3mg/ml) and dispase (4mg/ml),
incubate the tissues at 37C for about 45 minutes. 5. Add 5 volumes of culture
medium, alpha-MEM, with 10% serum. Centrifuge the sample at 1200 rpm for
10minutes, then suspend the cell pellet in culture medium. By using a 70-um pore
size strainer, pass the cells to obtain single-cell suspensions. 6. Plate the cells into
culture dishes with culture medium containing alpha-MEM with 10% fetal calf
serum (FCS), 100 uM L-ascorbic acid 2-phosphate, 2 mM L-glutamine, penicillin
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(100 U/ml), and streptomycin (100 mg/ml). Incubate the cells at 37C with 5% CO2.
7. Cells grow slowly in the beginning and it takes about 2 weeks to observe single
colonies (Liu et al., 2006).

Pulp Immunology

The dental pulp is a very special tissue in our body because it’s enclosed in a hard
tissue just like our brain, and as long as this hard barrier is undamaged, the pulp
will remain healthy and functional. However, when this barrier is damaged by
carious lesions, dental trauma or operative dental procedures, microbial
components can be introduced to the pulp (Bergenholtz, 1990).

Pulpal inflammation involves complicated processes and various types of immune
cells. Before looking into the details of each process of pulpal inflammatory
responses, we will go over the basic immune components of the human pulp.
The classic immunohistochemical analysis of the human dental pulp done by
Pulver et al., in 1977 showed the difference between the immune components of
normal and inflamed human pulp by looking at immunoglobulin-containing cells
(ICC). According to their study, there was virtually no immune components that are
necessary for immunoglobulin synthesis in the dental pulp. However, in the
inflamed dental pulp tissues, various ICCs were detected including IgG, IgA and

10

IgE with IgG being the most prominent (Pulver et al., 1977). More recently in 2015,
Gaudin et al., collected healthy human third molars from 42 young patients and
quantified the immunocompetent cells in the human dental pulp by utilizing
fluorescence-activated cell sorting, followed by flow cytometry and immunostaining
analyses. According to their studies, leukocytes or CD45+ cells represented about
0.94%+/-0.65% from the whole dental pulp tissues following enzymatic digestion.
Granulocytes/neutrophils CD16+CD14+ (50.01%) cells were found to be the most
prominent subpopulation within the CD45+ cells. CD3+ T lymphocytes (32.58%),
CD14+ monocytes (8.93%), HLA-DR Lin1- dendritic cells (4.51%), CD3-CD56+
natural killer cells (2.63%), CD19+ B lymphocytes (1.65%) were also detected in
the healthy human pulp (Gaudin et al., 2015).

The detailed mechanism of pulpal inflammation involves an extensive number of
immune cells both from innate and adaptive immune responses. Host immune
response to microbial insult to the dentin/pulp complex is a double-edged sword,
because if the issue is not resolved, it leads to collateral damage to the tissue,
leading to necrosis (Cooper et al., 2014).
When there’s a microbial invasion to the pulp, innate immune response is activated.
When the innate immune response is not adequate to stop the insult, adaptive
immune response is elicited to augment protective mechanisms by cellular and
specific antibody responses (Hahn & Liewehr, 2007).
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Generally, innate immune response does not require specific antigen recognition;
rather, it uses molecular patterns that are commonly found in microbes (Abbas &
Lichtman, 2003). Cells that express the major histocompatibility complex (MHC)
will first recognize the microbes and react accordingly (Holland & Botero, 2014).
There are type I and II MHC cells. Type I MHC cells are essentially all the
nucleated cells in the body and they are considered “antigen-recognition” cells, and
the type II MHC cells are considered antigen-presenting cells, because they take
part of antigen and travel through the lymphatic system to present the antigen to T
cells (Holland & Botoero, 2014). Usually, after recognition, these microbes are
internalized and killed through the process called phagocytosis by immune cells
like neutrophils and macrophages (Hahn & Liewehr, 2007).

In oral mucosa, typical components of innate immunity include epithelial barriers,
circulating cells and proteins, and these components recognize microbes or the
substances made from microbes to stop the microbial invasion (Hahn & Liewehr,
2007). However, the components of the innate immunity in the dentin/pulp complex
are a bit different from those of the oral cavity. According to Hahn and Liewehr
2007, these components include dentinal fluid and intratubular immunoglobulins,
odontoblasts, neuropeptides and neurogenic inflammation, innate immune cells
including natural killer (NK) cells, T cells, and immature dendritic cells (DCs) and
their cytokines and chemokines. According to the literatures, the transition from the
innate to adaptive immune response occurs during the progressing stages of
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reversible pulpitis (Hahn & Liewehr, 2007).

We will briefly review each component of innate immunity in the dentin/pulp
complex. The first unique component of the innate immunity in the human pulp is
the dentinal fluid and intratubular immunoglobulins (Hahn & Liewehr, 2007). When
there’s positive intrapulpal pressure due to initial immune response to carious
lesions, the outward flow of dentinal fluid is increased which can decrease the
amount of noxious stimuli coming through the dentinal tubules (Matthews &
Vongsavan 1994). Additionally, dentinal fluid contains serum proteins and
immunoglobulins (Knutsson et al., 1994). Especially, when there’s deep carious
lesion, the concentration of certain immunoglobulins including IgG1, IgA1, IgA2,
and IgM increase in dentinal tubules (Hahn & Best, 2006).
Another unique component of innate immunity in the dentin/pulp complex is
odontoblasts. These cells have cellular processes that extend into the dentinal
tubules and they are usually the first cells to encounter the microbial invasion from
carious lesions (Hahn & Liewehr, 2097). Odontoblasts express Toll Like Receptors
(TLRs) which are known to be part of innate immunity (Copper et al., 2014).
Odontoblasts also secrete chemokines like CCL2 and CXCL10 which can attract
immature Dendritic cells and leukocytes (Hahn & Liewehr, 2007).
Neuropeptides and neurogenic inflammation also has an important role in innate
immune response (Hahn & Liewehr, 2007). In human pulp, sensory neuropeptides
like calcitonin gene-related peptide (CGRP), neurokinin A (NKA) and substance P
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(SP) are often found (Awawdeh et al., 2002). When there is pulpal injury, the
concentration of these neuropeptides increase which lead to neurogenic
inflammation (Bowles et al., 2003). This leads to the outward flow of dentinal fluid
and increase in interstitial tissue pressure (Hahn & Liewehr, 2007). Additionally,
when the pulp is inflamed, the concentrations of SP and CGRP are increased
which can lead to recruitment of immune cells including T cells and immature DCs
(Awawdeh et al., 2002).

The most common innate immune cells in the pulp include neutrophils,
mononuclear phagocytes, NK cells, T cells and immature DCs (Hahn & Liewehr,
2007). Neutrophils and macrophages act as phagocytes. NK cells also have an
important role because they can promote DC maturation and produce IFN-gamma
which activates macrophages and promotes type-I T cells responses in adaptive
immune response (Raulet, 2004). The common cytokines secreted in the innate
immune response include TNF-alpha, IL-1, IL-12, IL-18, IFN-gamma, IL-6 and IL10 (Abbas & Lichtman, 2003). The main role of TNF-alpha and IL-1 include
promotion of extravasation of phagocytes during inflammation (Hahn & Liewehr,
2007). IL-12, IL-18 and IFN-g are mainly associated with transitioning to the
subsequent type 1 adaptive cellular immune response from the innate immune
response (Trinchieri 1995). IL-10 acts as an inhibitor of macrophages and DCs to
control innate immune responses and cell-mediated immunity (Hahn & Liewehr,
2007).
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Lastly, chemokines, that are produced during the innate immunity, have the ability
to recruit neutrophils, monocytes, immature DCs, and lymphocytes to the site of
infections (Hahn & Liewehr, 2007).

Adaptive immune response is different from innate immunity in a sense that it is
antigen specific, but its main purpose is to augment the innate immune response.
The main players of adaptive immune response are antigen-specific lymphocytes
and their products, such as cytokines, chemokines and antibodies (Hahn &
Liewehr, 2007).

Chemokines play an important role; for example, during pulpal inflammation,
certain chemokine ligands are upregulated, such as monocyte chemotactic protein1 (CCL2/MCP-1), macrophage inflammatory protein 3-alpha (CCL20/MIP-3alpha),
and IL-8, and these can recruit more immune cells like monocytes, memory T cells,
NK cells, and immature DCs to amplify the immune response (Nakanishi et al.,
2001).
Antigen presenting cells (APCs) are the main component of adaptive immunity,
because they capture, process, and present the antigens to T cells (Holland &
Botero, 2014). The common APCs in the inflamed pulp are DCs and macrophages
in early pulpitis and B cells in irreversible pulpitis (Hahn & Liewehr, 2007).
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Besides lymphocytes, macrophages are crucial in pulpitis. The main roles of
macrophages include phagocytosis, antigen presentation and immunomodulation
(Fujiwara & Kobayashi, 2005). Macrophages are often activated by IFN-gamma
and once activated, they produce many different types of mediators involved with
inflammation including IL-1, IL-2, IL-10, TNF-alpha, chemokines, prostaglandins
and leukotrienes (Hahn & Liewehr, 2007).

T cells play an important role in adaptive immune response. Once T cells are
activated by APCs, they differentiate into different types of effectors cells including
CD4+ T helper cells, cytotoxic CD8+ T cells, Regulatory T cells (Treg) or memory
cells (Hahn & Liewehr, 2007). CD4+ T helper cells can be classified into type I T
helper cells (Th1) and type II T helper cells (Th2). Th1 cells and some non T helper
cells including CD8, NK cells or Treg produce type -1 cytokines like IFN-gamma,
IL-2, IL-12 and TNF-alpha (Hahn & Liewehr, 2007). All of these lead to stronger
cellular immune responses and prevent the production of type-2 cytokines. Th2
cells and some non T helper cells can produce IL-4 and IL-10 to suppress
macrophage activation and activate B cell proliferation and differentiation (Lebre et
al., 2005). According to the current literatures, concentration of both type-1 and -2
cytokines is elevated during pulpal inflammation (Hahn & Liewehr, 2007).

Cytotoxic CD8+ effector T cells can also be classified into different subtypes
including T cytotoxic-1 (Tc1), Tc2 and CD8+ Treg (Noble et al., 2006). Tc1 cells
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produce IFN-gamma while Tc2 cells produce IL-5 (Mosmann et al.,1997). CD8
Treg cells act to suppress immune responses by producing IL-10 (McGuirk & Mills,
2002). However, the distribution of these cytotoxic CD8+ effector T cells in
reversible pulpitis are not clearly known yet (Hahn & Liewehr, 2007).

Even during early pulpitis, B cells appear to participate in protective mechanism,
and their involvement increases significantly as the carious lesions progress
toward the pulp (Hahn & Liewehr, 2007). The main functions of B cells include
producing antibodies and cytokines like IL-4, IL-10 and IFN-gamma, and
functioning as APCs (Bayry et al., 2005). According to immunohistochemical
analysis from Pulver et al., 1977, IgG tends to be the most prominent antibodies in
inflamed pulp tissues, and IgA and IgE are also commonly found during pulpal
inflammation. Although the presence of these antibodies in inflamed pulp has been
shown, their protective mechanisms have not been proven yet (Hahn & Liewehr,
2007). Additionally, some suggest that even if they are protective by providing
bacterial clearance by macrophages or continuous B-cell activation, it may still be
too late for cases of irreversible pulpitis (Hahn & Liewehr, 2007).

This may seem like an extensive review on immunology of pulpal inflammation.
However, there are still many unanswered mechanisms even with many attempts
being made to further the understanding of pulp immunology. The better
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understanding of pulp immunology can lead us to clinically keep the pulp healthy
with immunological pulp therapies in the future.

Role of Stem Cells in Pulpitis

Mesenchymal stem cells, especially the ones from bone marrow, are thoroughly
examined for their surface markers that are involved in the immune response. The
surface markers that are identified on MSCs include various cytokines like IL-1, IL4, IL-6, IFN-γ, TNF-α, growth factors, platelet-derived growth factor, TGF-β,
epidermal

growth

factor

(EGF),

insulin-like

growth

factor

(IGF),

bone

morphogenetic proteins (BMPs), chemokines, various adhesion molecules, and
surface molecules for cell to cell interactions (Deans & Moseley, 2000 and
Docheva, 2008). DPSCs have not been this extensively studied for their surface
markers but many studies have shown them to have similar pattern (Leprince et al.,
2011). In addition, the current literature is indicating that there are many cytokines
and growth factors that can influence the activity of DPSCs including the
recruitment, proliferation and differentiation. Studies have shown that TGF- β1,
VEGF, and FGF-2 can act as a positive regulator for chemokines for DPSC
recruitment. Numerous factors including platelet-derived growth factor (PDGF-BB),
VEGF, GFG-2, insulin-like growth factor (IGF-1) and TGF- β1 have been shown to
stimulate the DPSC proliferation (Leprince et al., 2011). Additionally, TGF- β1,
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TGF- β3, bone morphogenetic progein-7 (BMP7), BMP2, VEGF, IFN-g-2b, TNF-a,
and IL-1 have been identified as factors that can stimulate the differentiation of
dental stem cells (Leprince et al., 2011). All these factors are identified as positive
regulators of dental stem cells which can eventually lead to healing of the pulp.

However, there are certain factors that can reduce the healing potential of dental
stem cells. When there is microbial insult to the pulp, inflammatory responses lead
to interruption of DPSC differentiation and pulp homeostasis (Hozhabri et al. 2014).
During the pulpal inflammation, there is an increase in proinflammatory cytokines
like tumor necrosis factor alpha (TNFa) and IL-1β which can decrease the
dentinogenic potential of DPSC and IFN-g which can prevent the proliferation of
dental stem cells (Alongi et al. 2010). These lead to decreased collagen synthesis
and odontogenesis, degradation of collagen, and interruption of pulp tissue
regeneration (Hozhabri et al. 2014). With an increase in concentrations of TNFa
and IL-1β, nuclear factor-kB (NF-kB) becomes activated, which leads to higher
inflammatory response (Bonizzi & Karin, 2004). A study done by Hozhabri et al.
2014 showed that downregulation of the transcription factor NF-kB in the presence
of TNFa and IL-1β lead to enhancement of odontoblastic differentiation and
collagen matrix formation of DPSCs.

In addition to responding to the inflammatory signals during pulpal inflammation,
many current literatures have shown that DPSCs have anti-inflammatory and
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immunomodulatory properties. DPSCs have been shown to inhibit activated T-cell
response and suppress the proliferation of peripheral blood mononuclear cell
proliferation (Leprince et al. 2011). The immunomodulatory functions of DPSCs are
currently being thoroughly studied for their clinical application. For example, a
recent study by Omi et al. 2016 showed that transplantation of DPSC suppressed
inflammation in sciatic nerves for diabetic polyneuropathy in rats. Rats with
diabetes typically show extremely reduced sciatic nerve conduction velocities and
sciatic nerve blood flow; however, when DPSCs were transplanted into the
unilateral hindlimb skeletal muscles for these rats, there was a significant increase
in sciatic nerve conduction velocities and sciatic nerve blood flow (Omi et al., 2016).
In addition, DPSC transplantation lead to significantly lower concentration of
monocytes/macrophages and decreased tumor necrosis factor-alpha mRNA
expression, and increased expression of IL-10 (Omi et al. 2016). In addition,
currently, MSCs are being used for the clinical application for the treatment of graftversus-host-disease (GVHD) for their anti-inflammatory capacities (Leprince et al.,
2011). A study conducted by Yazid et al. showed that DPSCs isolated from
inflamed pulp tissues showed significantly decreased immunomodulatory functions
compared with DPSCs isolated from healthy pulp tissues. Healthy DPSCs were
able to suppress various inflammatory mediators including TNFa, TNFB, and IL-2,
and a significantly higher level of IL-10 was also detected in healthy DPSCs
compared with DPSCs from inflamed tissues (Yazid et al. 2013).

The
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immunosuppressive properties of dental stem cells can definitely influence the
future treatment of pathogenesis of the pulp.

IL-6 in Immunology

Interleukin 6 (IL-6) is a pleiotropic soluble mediator that’s involved with various
steps throughout inflammatory processes, because it induces synthesis of acute
phase proteins like CRP, fibrinogen, serum amyloid A, and it stimulates antibody
production and effector T cell development (Tanaka et al. 2014). IL-6 is generally
not produced in the steady state with no inflammation (Snick, 1990). IL-6 can
coordinate the activity of the innate and adaptive immune responses and regulate
B and T cell responses (Garbers et al., 2018). During early inflammation, the
release of IL-6 is promoted by proinflammatory cytokines like IL-1, TNFa, IFN-g,
platelet-derived growth factor, and IL-3 (Barnes et al., 2011). However, in general,
IL-6 can be secreted by many different cell types including monocytes and
macrophages, fibroblasts, keratinocytes, astrocytes, endothelial cells, activated B
cells and T cells (Garbers et al., 2018). IL-6 is produced during the acute phase of
inflammation and it alters the nature of leucokyte infiltrate from neutrophils to
monocyte/macrophages; thus controlling the transition from acute to chronic
inflammation (Gabay, 2006). The expression of endothelial leukocyte adhesion
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molecules including VCAM-1 and ICAM-1 increases with IL6 production which
leads to more recruitment of leukcoytes (Barnes et al., 2011).

IL-6 binds to IL-6 Receptor (IL-6R) and they bind to glycoprotein 130 (gp130) which
initiates intracellular signaling (Schaper & Rose-John, 2015). IL-6R is expressed
only a few cell types including hepatocytes, epithelial cells and some leukocytes
(Scheller et al., 2011). IL-6R also exists in a soluble form as sIL-6R, and some
cells can be stimulated by the complex of sIL-6R-IL-6, and this process has been
called IL-6 trans-signaling (Riethmueller et al., 2017, and Rose-John & Heinrich,
1994).
IL-6 has three very important biological roles which include macrophage
differentiation, bone metabolism and acute phase response (Garber et al., 2018).
IL-6 classic signaling induces the increased expression of IL-4 receptor which
leads to a gene expression toward M2 differentiation (Braune et al., 2017). The M2
state of macrophage is associated with anti-inflammatory and is very important for
regenerative functions (Garber et al., 2018). The classic signaling of IL-6 can also
activate osteoblasts by increasing the expression of RANKL, and osteoblasts can
secrete IL-6 which can lead to osteoclastic differentiation through trans-signaling
(Garber et al., 2018). Lastly, IL-6 expression leads to the production of acute phase
proteins. During inflammation, IL-6 binds to IL-6R on hepatocytes in the liver which
leads to activation of the Janus kinase (JAK) which leads to signal transducer and
activator of transcription (STAT) signaling and acute phase proteins including C-
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reactive protein, serum amyloid A2 protein, haptoglobin and fibrinogen (Garber et
al., 2018).
According to many studies, IL-6 is basically involved in almost every aspect of
innate immune response, ranging from accumulating neutrophils at the site of
infection to hematopoiesis (Hunter & Jones, 2017). IL-6 is known to regulate
chemokines that activate neutrophils and is also involved with neutrophil apoptosis
(Hunter & Jones, 2017). IL-6 also has protective roles during innate immune
response by preventing excessive tissue damage through enhancing the transition
from the recruitment of neutrophils to that of monocytes/macrophages (Jones,
2005). In addition, IL-6 inhibits the activation of the transcription factor NF-kB, and
enhances the expression of the IL-1 receptor antagonist; thus it has an important
role in healing and resolution of inflammation (Hunter & Jones, 2017)

During the acute phase of inflammation, IL-6 stimulates the production of most
acute phase proteins (Gabay, 2006). During the initial phases of acute
inflammation, transcription factor NF-kB gets activated and it promotes the
transcription of the mRNA of inflammatory cytokines like tumor necrosis factor-a,
IL-1B and IL-6 (Tanaka et al., 2014). However, IL-6 plays another important role by
developing specific cellular and humoral immune responses like end-stage B cell
differentiation, immunoglobulin secretion and T cell activation (Gabay, 2006).
Additionally, IL-6 may play a role in chronic inflammation by rescuing T cells from
apoptosis; thus enhancing a chronic inflammatory cell infiltrate (Barnes et al.,
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2011). IL-6 also has pivotal roles in adaptive immunity and one of which includes
the induction of the maturation of B cells into plasma cells (Hunter & Jones, 2017).
This relationship has been heavily studied in many studies and in Castleman’s
disease, where there’s an increased concentration of IL-6 followed by B cell
hyperplasia (Yoshizaki et al., 1989). IL-6 interacts with CD4+ T cells by inducing
the transcriptional repressor Bcl-6 which enhances these cells to be committed to
the follicular helper T cells which are the cells that promote B cell proliferation and
immunoglobulin class switching (Hunter & Jones, 2017).

Current literatures have shown that IL-6 has various roles in acute and chronic
phases

of

inflammation,

autoimmunity,

endothelial

cell

dysfunction

and

fibrogenesis, and IL-6 has the two completely opposite roles during inflammation
(Gabay, 2006). During acute phase of inflammation, it has anti-inflammatory
functions by suppressing the concentration of proinflammatory cytokines like IL-1,
while it has a detrimental effect during chronic inflammation because it promotes
accumulation of mononuclear cells at the site of injury (Gabay, 2006).

In addition, IL-6 is deeply associated with proliferation, survival and commitment of
T cells and their cytokines (Hunter & Jones, 2017). IL-6 is involved in development
of commitment to specific effector subsets including Th17, Th22 and Tfh subsets
(Hunter & Jones, 2017). IL-6 binds to IL-6R on naïve T cells which leads to
promotion of retinoic acid receptor-related orphan nuclear receptor-gamma (ROR-
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gamma) expression which is the main transcription factor for Th17 cells (Garbers
et al., 2018). IL-6 also controls the differentiation of naïve T cells to the T follicular
helper cells (Garbers et al., 2018). Additionally, IL-6 can also determine the T cell
recruitment by expressing certain chemokine receptors or IL-6 trans-signaling on
stromal tissues that controls inflammatory chemokines. IL-6 also regulates the
proliferation and survival of Th1 and Th2 cells (Hunter & Jones, 2017).
IL-6 is very deeply involved with B cells because not only it promotes B cell
differentiation and proliferation and induction of immunoglobulins by plasma, but it
also becomes expressed by B cells (Garbers et al., 2018). IL-6 induces STAT3
activation which induces BLIMP1 expression which is important for the terminal
differentiation of plasma cells (Shapiro-Shelef, 2005). IL-6 also leads to expression
of IL-7R which leads to induction of recombinase genes RAG1 and RAG2, and
these genes are required for the B cell receptor editing (Hillion, et al., 2007).
Additionally, IL-6 has immunomodulatory function by inducing IL-10 producing B
regulatory cells (Rosser et al., 2014).
Since IL-6 also has an important role as a transitioning molecule from innate to
adaptive immune response, the impaired IL-6 activity leads to compromised
immune response to infection (Hunter & Jones, 2015)
IL-6 has been shown to be involved with its elevated concentration in various
inflammatory diseases including rheumatoid arthritis, juvenile idiopathic arthritis,
systemic lupus erythematosus, psoriasis, ankylosing spondylitis, and Crohn’s
disease (Gabay, 2006)
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When IL-6 was first identified, it was known for its abilities to regulate the acutephase immune response, activate T cells, and differentiate B cells (Hunter and
Jones, 2015). Recently, IL-6 is being heavily studied for its hormone-like traits
which can be associated with lipid metabolism, vascular disease, mitochondrial
activities, insulin resistance, neuropsychological behavior and neuroendocrine
system (Hunter and Jones, 2015).

IL-6 in Pulpitis

The presence of IL-6 in human dental pulp and periapical lesions was detected by
Barkhordar et al. in 1999. According to their study, the concentration of IL-6 from
the periapical samples from lesions and inflamed pulpal tissues was significantly
higher than the control group by using ELISA. Many studies following Barkhordar
et al. in 1999 showed very similar results where there is a significantly higher
concentration of IL-6 in inflamed pulp tissues when compared with that of in
healthy pulp tissues (Sabir & Sumidarti, 2016 and Park, 2002). As we have
reviewed so far, IL-6 is one of the key mediators that are involved in the
inflammatory responses. The increased concentrations of IL-6 have been detected
in various oral diseases, and the prolonged excessive IL-6 production can lead to
chronic inflammation, followed by tissue damage and loss of periodontal ligament
and alveolar bone (Nibali et al., 2011).
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Although IL-6 is being thoroughly studied currently, there is no extensive review on
the exact function of IL-6 in the human pulp tissues. Many attempts are being
made to investigate the role of IL-6 in pulpal inflammation in relation to stem cells.

IL-6 and Osteogenesis

IL-6 has been found to have both pro- and anti-inflammatory functions; therefore,
many studies have been performed to investigate their role in inflammatory bone
destruction following pulpal inflammation/infection. IL-6 has the ability to stimulate
the formation of osteoclast precursors which leads to increased concentration of
osteoclast, then to bone resorption (Kurihara et al., 1990). However, other studies
have shown that IL-6 also has the opposite role by upregulating tissue inhibitor of
metalloproteianses-1

and

inducing

acute-phase

proteins

that

have

anti-

inflammatory properties (Akira et al., 1993). A study done by Balto et al., in 2001
conducted experiments to investigate the net effect of IL-6 in inflammatory bone
destruction by using IL-6-/- (knockout) mice. According to the analysis on the
samples from the periapical lesions caused by pulpal infection, bone destruction
was significantly increased in IL-6 knockout mice, meaning IL-6 has antiinflammatory functions and can modulate bone destruction in vivo (Balto et al.,
2001).
Studies have shown that the levels of IL-6 and IL-6R are increased during
osteogenic differentiation in bone marrow mesenchymal stem cells (BM-MSCs)
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(Xie et al., 2018). The IL-6 and IL-6R complex activate the downstream STAT3
signaling pathway which leads to osteogenic differentiation in BM-MSCs (Chalaris
et al., 2011). The neutralizing antibodies against IL-6 or IL-6R have shown to
decrease the osteogenic differentiation of BM-MSCs to confirm their role (Xiet et al.,
2018).

There are many other studies that indicate the role of IL-6 in promoting osteogenic
differentiation through many different pathways. For example, a study done by
Huang et al. in 2018 showed that IL-6 and soluble IL-6R can increase BMP-2
induced osteogenic and adipogenic differentiation of human BMSCs through
increasing BMPR1A-mediated BMP/Smad and p38 MAPK pathways (Huang et al.,
2018).

IL-6 and Neurogenic Differentiation

Neural stem cells (NSCs) are known to have a very high neurogenic differential
potential which can replace damaged cells, and regenerate and re-myelinate host
axons through paracrine effects (Jung et al., 2016). Similar to NSCs, DPSCs also
have the capacity to differentiate into neural-like cells; therefore, they are a good
candidate for neural regeneration (Ibarretxe et al., 2012). For an example, a study
done by Jung et al. in 2016 showed that when DPSCs were transplanted into the
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brain and injured spinal cord in rats, they were able to survive and express
neuronal markers including nestin and Sox2. Therefore, DPSCs, especially with
their cranial neural crest lineage, are an attractive source for neural regeneration
and repair in nerve-related diseases in addition to their immunomodulatory factors
(Luo et al., 2018).

IL-6 also plays an important role in neurogenic inflammation. IL-6 can induce the
generation of neurogenic inflammation and pain generation (Ebbinghaus et al.,
2015). However, there is no studies conducted on its role on neurogenic
differentiation of mesenchymal stem cells.
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MANUSCRIPT

Introduction
Interleukin 6 (IL-6) is a pleiotropic soluble mediator that is involved in various steps
throughout inflammatory processes (Tanaka et al. 2014). IL-6 can coordinate the
activity of the innate and adaptive immune responses and regulate B and T cell
responses (Garbers et al., 2018). IL-6 is produced during the acute phase of
inflammation and it alters the nature of leukocyte infiltrate from neutrophils to
monocyte/macrophages; thus controlling the transition from acute to chronic
inflammation (Gabay, 2006). Although IL-6 has been thoroughly investigated for its
role and relationships with various types of immune cells, there is not yet an
extensive review on its relationship with dental pulp stem cells (DPSCs).
DPSCs were first isolated from adult human dental pulp, and their clonogenic and
proliferative properties were similar to human bone marrow mesenchymal stem
cells (BMSCs) (Gronthos et al., 2000). DPSCs have the potential to differentiate
into many different cell types in vitro such as osteoblasts, chondrocytes, adipocytes,
myocytes, neurons, and hepatocytes (Karamzadeh & Eslaminjad, 2013).
Furthermore, recent studies have shown DPSCs have immunomodulatory effect on
immune cells (Lee et al., 2016 & Zhao et al., 2012). In addition, a subset of MSCs
also has been isolated from inflamed human pulps (I-DPSCs) and shown the full
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capability of proliferation and multi-potent differentiation as compared to those from
healthy pulps (H-DPSCs) (Alongi et al., 2010 & Pereira et al., 2012).
Studies have shown that the level of IL-6 is increased during osteogenic
differentiation in BMSCs (Xie et al., 2018). IL-6 can activate the downstream
STAT3 signaling pathway which leads to osteogenic differentiation of BMSCs
(Chalaris et al., 2011). The neutralizing antibodies against IL-6 have shown to
decrease the osteogenic differentiation of BM-MSCs to confirm their role (Xie et al.,
2018). IL-6 also plays an important role in neurogenic inflammation. IL-6 can
induce the generation of neurogenic inflammation and pain (Ebbinghaus et al.,
2015). However, there is no extensive study conducted on its role on neurogenic
differentiation of MSCs.
Including the study done by Barkhordar et al., in 1999, many studies have shown
that there is a significantly higher concentration of IL-6 in inflamed pulp tissues
when compared with that of in healthy pulp tissues (Sabir & Sumidarti, 2016, Park,
2002). However, there are no studies to demonstrate the interaction of IL-6 with
DPSCs in healthy and inflamed pulp tissues and the effect of IL-6 on the
differentiation potential of DPSCs.
Therefore, I hypothesized that IL-6 can promote osteogenesis while inhibiting
neurogenesis from DPSCs. The aims of this study were to investigate the baseline
differences between the H-DPSCs and I-DPSCs, and determine how IL-6 can
affect the osteogenic and neurogenic differentiation potentials of DPSCs.
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Materials and Methods
Subjects and Primary Culturing
Healthy impacted third molars from patients with 17-27 years of age, and severely
decayed molars with no restorability and spontaneous, sharp shooting pain from
patients with 24-56 years of age were collected at the Oral Surgery Clinic at the
University of Pennsylvania School of Dental Medicine after informed consent was
obtained following the protocol approved by the Institutional Review Board of the
University of Pennsylvania.
A total of 20 patients with ages, that range from 17 to 56 years of age, with no
systemic diseases were seen at the Oral Surgery Clinic at the Penn Dental
Medicine, and a total of 28 molars were extracted from these patients. Eight
healthy impacted third molars from four patients were used for four cultures of
primary culturing of H-DPSCs (two teeth from each person per culture); two healthy
impacted third molars for H & E staining; four healthy impacted third molars for
Toluidine Blue staining. Eight severely decayed molars from four patients were
used for four cultures of primary culturing of I-DPSCs (two teeth from each person
per culture); two severely decayed molars for H & E staining; four severely
decayed molars for Toluidine Blue staining.
Tooth surfaces were scraped to remove gingival tissues and they were disinfected
with 70% ethanol and rinsed with 1x phosphate-buffered saline (PBS). By using a
sterilized dental bur, each tooth was cut at the cementum-enamel junction, and the
pulp tissue was gently taken out with sterilized tweezers. Only the coronal portion
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of pulp tissue from severely decayed teeth was used for I-DPSC culturing to
ensure only the inflamed areas are being affected. The pulp tissues were minced
with a scalpel and were digested in a solution of 3mg/ml collagenase type I
(Worthington Biochem, Freehold, NJ) and 4mg/ml dispase (Boehringer Mannheim)
for 1 hour at 37 °C. The single-cell suspensions were obtained by using a 70- µm
pore size strainer (Falcon) to pass the cells. Cells were plated into culture dishes
with culture medium containing a-MEM (Invitrogen) with 10% fetal bovine serum
(FBS) (Gemini), 100 µM L-ascorbic acid 2-phopshate (Wako Pure Chemicals,
Osaka) / 2mM L-glutamine/ 100 units/ml penicillin, 100 µg/ml streptomycin
(Biofluids, Rockville, MD), and they were incubated at 37°C in 5% CO2.

Colony-Forming Unit-Fibroblasts (CFU-F) Assay and Proliferation Assay
After 14 days of culturing, cells were fixed with 4% formalin and then stained with
0.1% toluidine blue for the assessment of colony-forming efficiency. A colony was
defined as aggregates that are consisted of more than 50 cells. The proliferation
rate of subconfluent cultures of healthy and inflamed DPSCs was investigated with
bromodeoxyuridine (BrdU) incorporation for 10 hours by using a BrdU Staining Kit
(Invitrogen) following the manufacturer’s instructions. By using ten image areas per
subject, BrdU-positive and total cell numbers were counted. The BrdU-positive
cells were quantified as a percentage of the total number of cells.
In order to investigate the healthy and inflamed pulp tissues, the samples were
fixed with 4% paraformaldehyde (Sigma-Aldrich), decalcified with 5% EDTA, then
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embedded in paraffin. These paraffin sections (6µM) were then stained with
hematoxylin and eosin (H&E). The ImageJ software was used to analyze the
stained pulp tissues.

Flow Cytometric Analysis
In order to analyze the baseline stem cell markers for DPSCs, healthy and
inflamed DPSCs were incubated with various antibodies, including CD44, CD73,
CD90, CD105, CD34, and CD45. CD44, CD73, CD90, and CD105 were used as a
positive marker while CD34 and CD45 were used as a negative marker for DPSCs.
The FACSCalibur with CellQuest software was used for the analysis.

Immunofluorescence Staining
In order to perform immunofluorescence staining, frozen sections were prepared.
The slides were stained with CD3, CD105 and IL-6, followed by secondary
antibody staining.
For the assessment of neurogenic differentiation of healthy and inflamed DPSCs,
the samples were cultured on 4-well chamber slides (Nunc, Rochester, NY, USA)
(2 x 103/well). They were incubated with neurogenic markers including MAP2 and
NeuN before and after the treatment with IL-6, followed by neurogenic
differentiation. The secondary antibody staining was done for all the slides, then
they were mounted with Vectashield mounting medium containing DAPI.
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Enzyme-linked Immunosorbent (ELISA) Assay
The levels of IL-6 from the culture supernatant from healthy and inflamed DPSCs
were measured with the Human IL-6 ELISA MAXTM Deluxe kit purchased from
Biolegend, following the manufacturer’s instructions.

IL-6 Treatment to Healthy and Inflamed DPSCs
In order to examine the role of IL-6 in osteogenic and neurogenic potentials of
DPSCs from the healthy and inflamed pulp tissues, IL-6 was added. Since the level
of IL-6 in the culture supernatant from healthy DPSCs was lower than that of
inflamed DPSCs, IL-6 molecules (R&D Systems) were added to the culture
medium. In contrast, neutralizing IL-6 antibodies (Biolegend) (10µL per 1mL
medium) were added to the culture medium of inflamed DPSCs to reduce the
effects of IL-6.

Osteogenic Differentiation Assay
For the assessment on the difference between the healthy and inflamed DPSCs
and on the role of IL-6 on DPSCs, four different sets of DPSCs were used. Healthy
DPSCs, Inflamed DPSCs, healthy DPSCs treated with additive IL-6 and inflamed
DPSCs with neutralizing IL-6 were loaded at 1 x 106 per well into a 6-well plate.
Osteogenic differentiation was induced when cells reached 100% confluence. The
osteogenic medium contained 2mM ß-glycerophosphate (Sigma), 100 µM Lascorbic acid 2-phosphate (Sigma) and 10 nM dexamethasone (Sigma). In order to
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assess the osteogenic markers including OCN and Runx2, total protein was
isolated from cultured DPSCs after 14 days of osteogenic induction, and then the
Western blot analysis was performed. After 2 weeks of osteogenic induction, the
cells were stained with 1% alizarin red-S (Sigma) and the ImageJ software was
used for the analysis.

Neurogenic Differentiation Assay
Similar to the osteogenic differentiation assay, four different sets of DPSCs were
used including healthy DPSCs, inflamed DPSCs, healthy DPSCs treated with
additive IL-6 and inflamed DPSCs with neutralizing IL-6. These cells were then
loaded at 1 x 106 per well into a 6-well plate. Neurogenic differentiation was
induced when cells reached 100% confluence and the neurogenic medium
contained DMEM (Invitrogen) with 10% FBS, 1 x N-2 supplement (Life
Technologies), 100 U/mL penicillin, 100 µg/mL streptomycin, 10 ng/mL fibroblast
growth factor 2, and 10 ng/mL epidermal growth factor (R&D Systems, Minneapolis,
MN, USA). After 14 days of neurogenic induction, the neurogenic markers
including NeuN and MAP2 were assessed through the Western blot analysis after
total protein was isolated from the cultured DPSCs.

Western Blot Analysis
The M-PER mammalian protein extraction reagent (Thermo, Rockford, IL, USA)
was used to extract total protein from the samples. The concentrations of proteins
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were measured by using protein concentration assay (Bio-Rad Laboratories). 20
µg of proteins were applied and separated by SDS PAGE gel and they were
transferred to 0.2 µm nitrocellulose membranes (Millipore). The membranes were
then blocked with 5% non-fat dry milk and 0.1% tween-20 for 1 hour. The
membranes were incubated overnight with the primary antibodies diluted in
blocking solution following manufacturer’s instructions. Antibodies to human Runx2,
ALP, NeuN, and MAP2 were purchased from Santa Cruz Biotechnology, Inc., and
antibodies to mouse ß-actin were purchased from Abcam. For the secondary
binding, the membranes were incubated for 1 hour in HRP-conjugated secondary
antibody (Santa Cruz Biotechnology, Inc.). The SuperSignal West Pico
Chemiluminescent Substrate (Thermo Fisher Scientific) and BioMax film (Kodak)
were used to detect the immunoreactive proteins. With the ImageJ software, the
bands were analyzed with ß-actin as a control.

Statistical Analysis
The independent unpaired two-tailed Student’s t-tests were used when comparing
between two groups. P-values less than 0.05 were considered statistically
significant.

Results
Baseline characteristics of Healthy and Inflamed Pulp Tissues
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Although there are many studies on analyzing the differences between the DPSCs
from healthy pulp tissues (H-DPSCs) and the ones from inflamed pulp tissues (IDPSCs), functions of these DPSCs vary slightly from each studies. Therefore, we
used our own samples to investigate the baseline characteristics of H-DPSCs and
I-DPSCs first.
As mentioned above, the results come from four different sets of H-DPSCs and IDPSCs for culturing, two different sets of pulp tissues for healthy and inflamed pulp
tissues for H&E staining, and four different sets of H-DPSCs and I-DPSCs for
Toluidine Blue staining for assessment of proliferation rate.

Figure 1. H & E staining of healthy and inflamed pulp tissues

20xMag

Figure 1a. Healthy pulp tissue

20xMag

Figure 1b. Inflamed pulp tissue

The H & E staining of healthy and inflamed pulp tissues serve two purposes. Firstly,
it is to confirm that diagnosis on healthy and inflamed teeth are correctly made by
examining the infiltrates of the pulp tissues. Secondly, it is used for general
characterization of healthy and inflamed pulp tissues. As seen in figure 1, normal
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pulp tissue is made up with blood vessels, connective tissues, red blood cells,
small number of lymphatic cells and nervous elements, while inflamed pulp tissue
is filled with immune cells, indicative of severe inflammation.
Figure 2. Immunofluorescence staining of healthy and inflamed pulp tissues
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CD105

CD105

Inflamed DPSCs

H-DPSC with CD105 (g)
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IL-6

IL-6

2c. H DPSC with CD3 (g)
Healthy DPSCs

2e. H-DPSC with IL-6 (g)

2f. I-DPSC with IL-6 (g)
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Immunofluorescence staining was performed to assess the difference between the
baseline characteristics of healthy and inflamed pulp tissues from frozen sections.
CD105 is a common surface marker for DPSCs, while CD3 and IL-6 are common
indicators of inflammation. As seen by the quantification analysis, while there was
no statistical difference between healthy (12.4% 41± 1.8) and inflamed (15% ± 4.2)
pulp tissues for CD 105, there were statistical differences between healthy and
inflamed pulp tissues for CD3 and IL-6 (p=0.000028 and p=00032, respectively).
The positively stained cells for CD3 were 4.69 % ± 2.7% and 19.3% ± 4% for
healthy and inflamed pulp tissues respectively, and for IL-6, they were 4.41 % ±
2.87% and 17.7% ± 5.79 % for healthy and inflamed pulp tissues respectively.

Baseline characteristics of Healthy and Inflamed DPSCs
Figure 3. CFU-F Assay
Inflamed DPSCs

Staining

Toluidine Blue

Healthy DPSCs

Figure 3a. Healthy DPSC

Figure 3b. Inflamed DPSC
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Figure 3c. Mean Number of Colonies Per 10,000 Cells Plated per well
In order to assess the proliferation capacities of H-DPSCs and I-DPSCs, the mean
number of colonies per 10,000 cells plated per well for primary culturing was
measured. The mean number of colonies for H-DPSCs was 32 with standard
deviation of 14.45, while it was 13.75 with standard deviation of 7.89 for I-DPSCs
with p value of 0.068. Due to the small sample size, even though there is a
substantial difference between the two groups, there was no statistical significance.
Each group had 4 samples, and H-DPSCs formed more colonies when compared
to I-DPSCs in general as seen in figure 3.
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Figure 4. Proliferation assay
Inflamed DPSCs

Figure 4a. H-DPSC

Figure 4b. I-DPSC
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Figure 4c. BrdU positive cells (% Total)
In addition to Toluidine Blue staining, the subconfluent H-DPSCs and I-DPSCs
were stained with BrdU for the assessment of proliferation capacities. The results
from BrdU staining was in agreement of the results from Toluidine Blue staining. HDPSCs had an average of 70.3 % ± 7.6 positively stained cells, while I-DPSCs had
an average of 49.16 % ± 4.13 positively stained cells. The results indicate that
even though DPSCs isolated from both healthy and inflamed pulp tissues have a
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high proliferation rate, H-DPSCs had a higher proliferation capacities compared to
I-DPSCs.

Figure 5. Flow cytometric analysis
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Acquisition Date: 20-Sep-17
Gate: G1
Gated Events: 10712
Operator: Administrator

Marker % Gated
All
100.00
0
M1
0.26
10
101

Marker % Gated
All
100.00
M1
0.07

Mean
1.18
2
8.16
10
103
FL2-H
I-DPSC

104

Table 1.
Marker
CD44
CD73
CD90
CD105
CD34
CD45

Mean
1.04
69.78

CD45

CD45

101

Mean
1.18
2
108.65
103
FL2-H

I-DPSC

H-DPSC

100

104

Mean
276.87
277.20

I-DPSC

CD34

100

Mean
441.25
2
441.85
10
103
FL2-H

Normal DPSC
(% Gated)
85.6
99.5
99.1
99.9
0.24
0.26

Inflamed DPSC
(% Gated)
99.6
99.8
99.8
99.9
0.01
0.07
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Mean
1.17
190.38

The flow cytometric analysis was performed on H-DPSCs and I-DPSCs to confirm
the purity of stem cell components in the cell culture and to assess the difference
between the H-DPSCs and I-DPSCs. CD44, CD73, CD90 and CD105 are
considered typical positive stem cell markers while CD34 and CD45 are
considered negative markers. As summarized in Table 1, both H-DPSCs and IDPSCs were positive for CD44, CD73, CD90 and CD105, while both were negative
for CD34 and CD45. These results indicate that the cell cultures for both H-DPSCs
and I-DPSCs were purely composed of DPSCs, and there was no statistical
difference between them with regards to these markers.

Presence of IL-6 in Culture Supernatant from Healthy and Inflamed DPSCs
As mentioned by Barkhordar et al. in 1999, the inflamed pulp tissues contain higher
concentration of IL-6 compared to the healthy pulp tissues. ELISA was performed
on the culture supernatant from healthy and inflamed DPSCs to investigate if there
is a difference in the level of IL-6. On average from our samples, H-DPSCs
contained 16pg/mL of IL-6 in their culture medium while I-DPSCs contained
119.5pg/mL of IL-6. These results indicate that I-DPSCs have the capacity to
produce a higher concentration of IL-6 with statistical significance (p value < 0.01).
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Figure 6. Concentration of IL-6 in culture supernatant from H-DPSCs and I-DPSCs
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Figure 7. Osteogenic differentiation potential with Alizarin Red staining and
western blotting
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OCN

37KD

ß-Actin
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Figure 7c. Western Blotting for OCN

Runx2

65KD

ß-Actin

42KD

Figure 7d. Western Blotting for Runx2

Although DPSCs are known to have high osteogenic differentiation potentials,
there are still conflicting data on the difference between H-DPSCs and I-DPSCs for
their capacities for osteogenic differentiation. Therefore, our samples were induced
for osteogenesis, and the Alizarin Red staining and the western blotting analysis
were performed to assess the difference between H-DPSCs and I-DPSCs. Figure
6 shows both samples have osteogenic differentiation potential. Interestingly, IDPSCs had stronger Alizarin Red staining and thicker bands for osteogenic
markers, Osteocalcin (OCN) and Runx2.
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Comparison on Neurogenic Differentiation Potentials between Healthy and
Inflamed DPSCs

Figure 8. Neurogenic differentiation potential analysis with immunofluorescent
staining and western blotting
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Figure 8e. Western Blotting with NeuN
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Figure 8f. Western Blotting with GAD6
In addition to osteogenic differentiation, DPSCs are also capable of neurogenesis
(Ibarretxe et al., 2012). Our DPSCs samples were induced for neurogenesis, and
immunofluorescence and western blotting were performed to investigate if there is
any difference between H-DPSCs and I-DPSCs.
Immunofluorescences showed that H-DPSCs are more highly stained with
neurogenic markers including MAP2 and NeuN than I-DPSCs. According to the
quantification analysis, 97.2 % (± 2.3%) and 98.3 % (± 1.2%) of H-DPSC samples
were positively stained for MAP2 and NeuN respectively, while 68.5% (± 13.3%)
and 61.7% (±11%) of I-DPSCs samples were positively stained for MAP2 and
NeuN respectively. Likewise, the expression of NeuN and GAD6 was more
strongly detected in H-DPSCs compared with I-DPSCs.

Effects of IL-6 on Osteogenic and Neurogenic Differentiation Potentials of
DPSCs
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Figure 9. Osteogenic differentiation potential of IL-6 treated H-DPSC and I-DPSC
H-DPSC
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Figure 9e. Western Blotting for OCN
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Figure 9f. Western Blotting for Runx2
Since our findings indicate that there are statistical differences between H-DPSCs
and I-DPSCs on the secretion of IL-6 during culturing, and osteogenic and
neurogenic differentiation, additional experiments were performed to investigate
the role of IL-6 on the differentiation potentials of two different types of DPSCs.
Based on Alizarin Red staining and western blotting analysis, IL-6 has an effect on
DPSCs for their osteogenic differentiation potentials. Upon stimulation with IL-6, HDPSCs had higher osteogenic differentiation, as seen by stronger Alizarin Red
staining and stronger expression of osteogenic markers including OCN and Runx2
compared to those from non-stimulated H-DPSCs.
In contrast, when neutralizing IL-6 was added to prevent the action of IL-6 for IDPSCs, a higher degree of osteogenic differentiation was observed when
compared to I-DPSCs without neutralizing IL-6 based on weaker Alizarin Red
staining and stronger expression of osteogenic markers including OCN and Runx2.
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Figure 10. The expression of neurogenic markers in H-DPSC and I-DPSC in
immunofluorescence and western blotting
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Figure 10j. Western Blotting with GAD6

Immunofluorescence staining and western blotting analysis were performed to
assess the effect of IL-6 on neurogenic differentiation potentials of DPSCs. With
addition of IL-6, the neurogenic differentiation potentials of H-DPSCs seemed to be
decreased based on less immunofluorescence staining and weaker expression of
neurogenic markers including NeuN and GAD6. However, based on quantification
analysis from immunofluorescences, H-DPSCs without additional IL-6 had 97.2%
(±2.3%) for MAP2 and 98.3% (±1.2%) for NeuN for positively stained cells, while
H-DPSCs with additional IL-6 had 81.7% (±7.8%) for MAP2 and 88.4% (±3.6%) for
NeuN for positively stained cells. For I-DPSCs, there were 68.5% (±13.4%) for
MAP2 and 61.8% (±11%) for NeuN for positively stained cells, while I-DPSCs with
neutralizing IL-6 had 95.3 % (±3.2%) for MAP2 and 86.7 % (±5.8%) for NeuN for
positively stained cells.
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Discussion
The differences on baseline characteristics, including expressions for stem cell
markers, proliferation rate, and differentiation potentials, for H-DPSCs and IDPSCs have been thoroughly investigated by many different groups. However, the
results from these studies vary from one another, and there is no general
consensus yet. For example, Alongi et al. in 2010 showed that H-DPSCs have
higher osteogenic differentiation potentials and express lower levels of MSC
markers including STRO-1, CD90, CD105 and CD146 when compared to I-DPSCs,
while Wang et al. in 2010 showed that H-DPSCs showed similar STRO-1
expression and osteogenic induction potentials when compared to I-DPSCs (Alongi
et al. 2010 & Wang et al. 2010). However, Pereira et al. in 2012 showed that there
are more significant differences between each patient than there are between HDPSCs and I-DPSCs. In addition, there are not many literatures that assess the
difference between H-DPSCs and I-DPSCs on their neurogenic differentiation
potentials. Since there is no general consensus, experiments were performed to
investigate the baseline characteristics of H-DPSCs and I-DPSCs for their
proliferation rate by counting colony-forming unit and BrdU staining, stem cell
markers, and osteogenic and neurogenic differentiation potentials.

In order to investigate the general morphology of healthy and inflamed pulp tissues,
H & E staining was performed on two healthy pulp tissues collected from impacted
third molars and on two inflamed pulp tissues collected from severely decayed
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molars from paraffin sections. As expected, healthy pulp tissues were devoid of
immune cells, while inflamed pulp tissues were saturated with them. This result
confirms our selection criteria for choosing healthy and inflamed pulp tissues.

Immunofluorescence staining was performed to assess the difference between
healthy and inflamed pulp tissues from the paraffin sections from the same
samples that were used for H & E staining. CD105 was used as a stem cell marker
while CD3 and IL-6 were used as indicators for inflammation. Quantification
analysis was performed to assess how many cells are positively stained with
secondary antibodies for fluorescence. Five fields were randomly selected at 40
times magnification, and cells stained with DAPI and fluorescence were counted
for the analysis. For CD 105, there were 12.4% (±1.8) and 15% (±4.2) positively
stained cells for healthy and inflamed pulp tissues, respectively. Healthy pulp
tissues had 4.69% (±2.8) and 4.4 %(±2.9) positively stained cells for CD3 and IL6
respectively, while inflamed pulp tissues had 19.3% (±4.0) and 17.7% (±5.8)
positively stained cells for CD3 and IL-6 respectively. Interestingly, results showed
that there is no statistical difference between healthy and inflamed tissues for
CD105 (p=0.21) while there were statistical differences for CD3 (p=0.000029) and
IL-6 (p=0.00032), indicating that the concentration of DPSCs do not change much,
while levels of CD3 and IL-6 are increased during inflammation.
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In order to examine the proliferation rate of H-DPSCs and I-DPSCs, the colony
forming unit (CFU) and BrdU staining were analyzed. During primary culturing for
DPSCs, 10,000 cells for counted for four samples for H-DPSCs and I-DPSCs, and
were plated for assessing colony forming unit. For the first passage DPSCs grow in
colonies, and the number of these colonies represents the proliferation of each cell
line (Gronthos et al., 2000). After two weeks, cells were stained with Toluidine Blue
and colonies were defined as cells with more than 50 cells. The mean number of
colonies for H-DPSCs was 32 ± 14.4 and for I-DPSCs, it was 13.75 ±7.9.
According to our statistical analysis, there was no statistical difference between HDPSCs and I-DPSCs (p=0.068), even though H-DPSCs tended to have higher
number of CFU’s than I-DPSCs. This could be due to small sample size.

Additionally, BrdU staining was performed to further assess the proliferation rate of
DPSCs. BrdU stands for bromodeoxyuridine which is a synthetic nucleoside, and it
can be incorporated into the DNA of replicating cells by replacing thymidine during
DNA replication; therefore, it’s used for detecting proliferation cells (Lehner et al.
2011). For H-DPSCs, 70.3% (±7.6) cells were stained with BrdU, while 49.16%
(±4.1) were stained for I-DPSCs. The statistical analysis indicated that there is a
statistical significant difference between H-DPSCs and I-DPSCs (p=0.0006).

In addition, the flow cytometric analysis was performed to assess the purity of cell
cultures and to investigate if there is any difference between H-DPSCs and I-
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DPSCs. Markers that were evaluated include CD44, CD73, CD90, CD105, CD34
and CD45. CD44 is a cell membrane glycoprotein with lymphocyte activation
function, and its expression has been detected on DPSCs (Kawashima, 2012).
CD73 is also a positive marker for DPSCs and it is a cell adhesion molecule
(Alongi et al., 2012). CD90 is a glycoprotein expressed mainly in leukocytes and is
another positive marker for DPSCs (Kawashima, 2012). CD105 is also known as
endoglin which is a glycoprotein associated with the human vascular endothelium,
and is expressed on DPSCs (Rius et al. 1998). CD34 and CD45 are both
hematopoietic markers with CD34 commonly found in hematopoietic stem cells
and in endothelium and CD45 being a common leukocyte antigen, and these two
markers to be absent on DPSCs (Gronthos et al. 2000). For positive markers
including CD44, CD73, CD90, and CD105, both H-DPSCs and I-DPSCs had high
positive values, and they were both negative for CD34 and CD45 according to the
flow cytometric analysis. These results indicate that cell cultures included purely of
DPSCs, and there is no significant difference between H-DPSCs and I-DPSCs on
the expression level for stem cell markers.

IL-6 is involved in various steps through inflammatory processes, including
induction of synthesis of neutrophils and acute phase proteins. It is also involved in
coordination of the activity of the innate and adaptive immunities through
stimulation of antibody production and effector T cell development (Tanaka et al.,
2014). Although many attempts have been made to investigate the function of IL-6,
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little is known about its role in pulpal inflammation. One of the first studies on IL-6
from the dental field was done by Barkhordar et al. in 1999 where they showed that
there is an elevated level of IL-6 in inflamed pulp tissues and periapical lesions
compared to the healthy pulp tissues. Many studies, including Park in 2002 and
Sabir & Sumidartia in 2016, showed similar results where the level of IL-6 is
increased in inflamed pulp tissues. Based on these findings, our study conducted
an experiment to assess if I-DPSCs can play a role in increasing the level of IL-6.
According to the statistical analysis from ELISA, I-DPSCs expressed a higher level
of IL-6 compared to H-DPSCs (p<0.01). This result indicates that during
inflammation, DPSCs become activated to release IL-6.

Before investigating further into the role of IL-6, the baseline osteogenic and
neurogenic differentiation potentials were assessed for H-DPSC and I-DPSC
samples. As Pereira et al. in 2012 demonstrated that the differentiation potentials
vary among each sample. In this study, all four samples of H-DPSCs and another
four samples of I-DPSCs showed osteogenic and neurogenic differentiation
potentials, but as seen in figures 7 and 8, there were significant differences. When
compared to I-DPSCs, H-DPSCs had lower differentiation potentials for
osteogenesis, based on Alizarin Red staining and western blotting analysis for
osteogenesis markers including Runx2 and OCN. However, H-DPSCs had higher
neurogenic

differentiation

potentials

compared

to

I-DPSCs

based

on

immunofluorescence staining for neurogenic markers including MAP2 and NeuN,
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and western blotting analysis for GAD6 and NeuN. The quantification analysis for
immunofluorescence staining was done, and there was statistical difference
between H-DPSCs and I-DPSCs for MAP2 (p=0.0038) and NeuN (p=0.00011).
This result indicates that H-DPSCs have higher neurogenic differentiation
potentials from our samples. The effects of inflammatory processes on MSCs could
be a controversial topic. However, in general, when the levels of pro-inflammatory
cytokines including TNF-α, IL-1β, and INF-γ are elevated, pulp tissue regeneration
and dentinogenic differentiation potentials of DPSCs are decreased along with
collagen synthesis, odotogenesis and proliferation rates (Alongi et al., 2010).
Although the samples from our study show that H-DPSCs have higher proliferation
and neurogenic differentiation potentials with lower osteogenic differentiation
potentials compared to I-DPSCs, it does not implicate that inflammation leads to
such findings, because there are other factors involved and our sample size was
small to make such generalization.

Lastly, the role of IL-6 on the differentiation potentials for DPSCs were evaluated.
Based on our result from ELISA, I-DPSCs contained higher level of IL-6 in their cell
culture, while H-DPSCs contained minimum amount of IL-6. Therefore, IL-6 was
added to the cell culture of H-DPSCs, while neutralizing IL-6 was added to the cell
culture of I-DPSCs. The effect of anti-human IL-6 antibodies from the same
company on the neutralization has been investigated and proved by several
studies, including Zou et al. 1999 and Abrams 2001. The same experiments were
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performed to DPSCs treated with IL-6, following osteogenic and neurogenic
induction. Based on the Alizarin Red staining and western blotting analysis, IL-6
has a crucial role in osteogenesis for DPSCs. When IL-6 was added to H-DPSCs
culture, it led to stronger staining for Alizarin Red and thicker bands for osteogenic
markers including OCN and Runx2. When the activity of IL-6 was prevented by
adding neutralizing IL-6, osteogenic potentials of I-DPSCs were reduced based on
weaker Alizarin Red staining and thinner bands for osteogenic markers. Our results
are in agreement with other recent studies including Balto et al. 2001 and Xie et al.
2018, where it showed that IL-6 can lead to higher degree of osteogenesis. The
role of IL-6 on the neurogenic differentiation potentials seemed to be the exact
opposite of the osteogenic differentiation potentials. When IL-6 was added to HDPSCs, their neurogenic differentiation potentials seemed to have been reduced
based on the lower expression for GAD6 and NeuN from the western blotting
analysis and less immunofluorescence staining for NeuN and MAP2. Although both
samples were highly positively stained, according to our statistical analysis, there
was statistical difference between H-DPSCs and H-DPSCs with additive IL-6 for
MAP2 (p=0.0026) and NeuN (p=0.0003). This could be due to weaker effect of IL-6
on neurogenesis. When the neutralizing IL-6 was added to I-DPSCs, the
neurogenic potentials were reduced based on less expression on western blotting
and immunofluorescences. The quantification analysis showed that there were
statistical differences between I-DPSCs and I-DPSCs with neutralizing IL-6 for
MAP2 (p=0.0037) and NeuN (p=0.0027).
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In recent years, pulpal regeneration with the use of stem cell therapies has been
gaining much attention in the field of dental research. In 2017, Nakashima et al.
conducted a first human clinical study to regenerate pulp tissue by transplantation
of healthy DPSCs from wisdom teeth into pulpectomized teeth with the diagnosis of
irreversible pulpitis. In addition, Xuan et al. 2018 showed pulpal regeneration with
root maturation on 100% of teeth from the study population via autologous dental
pulp stem cell implantation on necrotic immature anterior teeth. From the findings
from our study, IL-6 has shown the ability to decrease the neurogenic
differentiation potential of DPSCs; therefore, neutralizing IL-6 antibodies can be
added on collagen to promote neurogenesis of DPSCs when being implanted into
the root canal space for pulpal regeneration which enhances the clinical success.

In addition, many studies are being conducted to investigate the ways to enhance
bone healing following endodontic surgeries, commonly known as apicoectomy. In
2011, von Arx and AlSaeed published a review paper on the use of regenerative
techniques in apical surgery and showed that many regenerative techniques are
being done including guided tissue and bone regeneration with membranes,
growth factors, bone fillers or bone substitutes. They mentioned that many studies
indicate that the regenerative techniques are needed for better outcome with
through-and-through lesions. From our study, it was shown that IL-6 has the
capacity to promote osteogenesis; therefore, IL-6 can be further investigated for
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the use as regenerative technique in endodontic microsurgery to promote faster
bone healing in the diseased area.

Conclusion
DPSCs are being thoroughly studied for their unique characteristics, not only for
dentistry but also for medicine nowadays. Our study is one of the very first and few
studies where the role of IL-6, another important molecule in our body, on
interactions with DPSCs is investigated. Our results indicated that H-DPSCs and IDPSCs express similar amount of stem cell markers, while H-DPSCs tend to have
higher neurogenic differentiation potentials and proliferation rate, and lower
osteogenic differentiation potentials when compared to I-DPSCs, although there
are variations among each samples. Furthermore, our results showed that the level
of IL-6 was elevated in the cell culture of I-DPSCs, which may indicate that IDPSCs are involved in the production of IL-6. In addition, IL-6 is capable of
promoting osteogenesis while inhibiting neurogenesis as seen by our results.
Our study is a pilot study where we showed that IL-6 has an effect on the
differentiation potentials of DPSCs. Further studies are required to examine the
detailed pathway of IL-6 interaction with DPSCs to develop the idea into promoting
healing capacities of DPSCs for pulpal regeneration and periapical bone healing.
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